Zimmer Biomet Holdings (ZBH) Cash from Operations (2016 - 2025)
Historic Cash from Operations for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $418.7 million.
- Zimmer Biomet Holdings' Cash from Operations rose 581.25% to $418.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 660.77%. This contributed to the annual value of $1.5 billion for FY2024, which is 519.73% down from last year.
- Per Zimmer Biomet Holdings' latest filing, its Cash from Operations stood at $418.7 million for Q3 2025, which was up 581.25% from $378.2 million recorded in Q2 2025.
- Over the past 5 years, Zimmer Biomet Holdings' Cash from Operations peaked at $588.4 million during Q4 2023, and registered a low of $223.5 million during Q1 2021.
- For the 5-year period, Zimmer Biomet Holdings' Cash from Operations averaged around $369.5 million, with its median value being $369.4 million (2024).
- The largest annual percentage gain for Zimmer Biomet Holdings' Cash from Operations in the last 5 years was 89356.06% (2021), contrasted with its biggest fall of 5043.25% (2021).
- Quarter analysis of 5 years shows Zimmer Biomet Holdings' Cash from Operations stood at $337.6 million in 2021, then fell by 27.67% to $244.2 million in 2022, then skyrocketed by 140.95% to $588.4 million in 2023, then dropped by 13.95% to $506.3 million in 2024, then dropped by 17.3% to $418.7 million in 2025.
- Its Cash from Operations stands at $418.7 million for Q3 2025, versus $378.2 million for Q2 2025 and $382.8 million for Q1 2025.